» Authors » Guangbing Xiong

Guangbing Xiong

Explore the profile of Guangbing Xiong including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 26
Citations 587
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Peng F, He R, Liu Y, Xie Y, Xiong G, Li X, et al.
Noncoding RNA Res . 2024 Jul; 9(4):1098-1110. PMID: 39022678
Cholangiocarcinoma is one of the most lethal human cancers, and chemotherapy failure is a major cause of recurrence and poor prognosis. We previously demonstrated that miR-200 family members are downregulated...
2.
Jin J, Xiong G, Peng F, Zhu F, Wang M, Qin R
Eur J Surg Oncol . 2024 May; 50(7):108355. PMID: 38703633
Background: We sought to combine skeletal muscle index and inflammatory immune markers to stratify long-term survival in patients with pancreatic cancer after pancreatoduodenectomy (PD). Methods: A total of 581 patients...
3.
Yang G, Qiu J, Xu J, Xiong G, Zhao F, Cao Z, et al.
Br J Surg . 2022 Nov; 110(8):908-912. PMID: 36357994
No abstract available.
4.
Li R, Xiong G, Zhao J, Yang L
Am J Transl Res . 2022 Oct; 14(9):5952-5964. PMID: 36247295
The chromatin remodeling gene AT-rich interactive domain 1A (), encoding a subunit of the switch/sucrose non-fermentable (SWI/SNF) complex, is one of the most frequently mutated chromatin regulators across a broad...
5.
Jin J, Wang H, Peng F, Wang X, Wang M, Zhu F, et al.
Hepatobiliary Surg Nutr . 2022 Jan; 10(6):825-838. PMID: 35004948
Background: The Naples prognostic score (NPS) is an effective and objective tool to assess the immune-nutritional status of patients with malignant tumors. The aim of this study was to investigate...
6.
Jin J, Xiong G, Wang X, Peng F, Zhu F, Wang M, et al.
Front Oncol . 2021 Dec; 11:748341. PMID: 34917503
Purpose: The aim of this study was to investigate the effect of preoperative and postoperative malnutrition on postoperative short- and long-term outcomes for ampullary carcinoma after pancreatoduodenectomy (PD). Methods: Data...
7.
Xiong G, Huang H, Feng M, Yang G, Zheng S, You L, et al.
J Exp Clin Cancer Res . 2021 Nov; 40(1):369. PMID: 34794494
No abstract available.
8.
Xiong G, Pan S, Jin J, Wang X, He R, Peng F, et al.
Front Oncol . 2021 Nov; 11:765216. PMID: 34760707
Pancreatic cancer (PC) is a highly malignant disease characterized by insidious onset, rapid progress, and poor therapeutic effects. The molecular mechanisms associated with PC initiation and progression are largely insufficient,...
9.
Cao Z, Qiu J, Guo J, Xiong G, Jiang K, Zheng S, et al.
J Gastroenterol . 2021 Aug; 56(10):938-948. PMID: 34453212
Background: Prophylactic somatostatin to reduce the incidence of clinically relevant postoperative pancreatic fistula after pancreaticoduodenectomy remains controversial. We assessed the preventive efficacy of somatostatin on clinically relevant postoperative pancreatic fistula...
10.
Yang G, Guan W, Cao Z, Guo W, Xiong G, Zhao F, et al.
Clin Cancer Res . 2021 Mar; 27(12):3383-3396. PMID: 33674273
Purpose: Gemcitabine is most commonly used for pancreatic cancer. However, the molecular features and mechanisms of the frequently occurring resistance remain unclear. This work aims at exploring the molecular features...